Join the 'Xeljanz' group to help and get support from people like you.
Xeljanz Support Group
Our support group for Xeljanz has 16 questions and 14 members. Updated 7 Apr 2016.
Pfizer Announces FDA Approval of Xeljanz XR (tofacitinib citrate), the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis
February 24, 2016 – Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets for the ...